← Eichor
Study identifier: NCT07085598 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of Vitamin D3 Supplementation on Cardiac Autonomic Nerve Function in Male Epileptic Patients With Hypovitaminosis D

Condition: Epilepsy  ·  Sponsor: Bangladesh Medical University

PhaseNA
Planned participants15
Who can joinMale, 20 Years to 40 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to see the effect of vitamin D3 supplementation on cardiac autonomic nerve function in male epileptic patients with hypovitaminosis D that weather vitamin D improves heart rate variability or not. The main questions it aims to answer are: 1. Does vitamin D improves cardiac autonomic tone in male epileptic patients? 2. Does vitamin D improves heart rate variability in male epileptic patients? It is a self control trial. Participants will: 1. undergo through baseline HRV testing 2. start to take vitamin D3 50000 IU once in a week for 8 weeks b) visit the university after 8 weeks for post interventional HRV testing . Researcher will compare the pre test and post test value of HRV testing.

This description comes directly from the study's public registry record.

Talk to the study team

Registrar, BMU  ·  +88 02 55165708  ·  registrar@bsmmu.edu.bd

Always discuss trial participation with your own doctor first.

Locations (1)

Bangladesh Medical UniversityDhaka, Shahbag, BangladeshRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07085598